Canada markets closed

PFE Jan 2023 57.500 call

OPR - OPR Delayed Price. Currency in USD
Add to watchlist
0.2500+0.0100 (+4.17%)
At close: 03:50PM EST
Full screen
Previous Close0.2400
Open0.3000
Bid0.2200
Ask0.2700
Strike57.50
Expire Date2023-01-20
Day's Range0.2300 - 0.4000
Contract RangeN/A
Volume646
Open Interest9.86k
  • Yahoo Finance

    'Almost every health care company will be in the in cloud' in the next 10 years: AWS exec

    Cloud computing is not a new frontier in health care, but it is finally starting to bear some fruit, AWS exec Dr. Taha Kass-Hout, told Yahoo Finance.

  • Reuters

    U.S. CDC expands use of bivalent COVID vaccines for kids as young as 6 months

    The U.S. Centers for Disease Control and Prevention (CDC) on Friday expanded the use of COVID-19 vaccines that target both the original coronavirus and Omicron sub-variants to include children aged 6 months through 5 years. The development comes a day after the U.S. Food and Drug Administration authorized the updated shots from Moderna as well as Pfizer and its partner BioNTech for use in children as young as 6 months. Children aged 6 months through 5 years will now be eligible to get a Moderna bivalent booster 2 months after their final primary vaccination dose for COVID-19.

  • Business Wire

    Pfizer Declares First-Quarter 2023 Dividend

    NEW YORK, December 09, 2022--Pfizer Inc. (NYSE: PFE) today announced that its board of directors declared an increase in the quarterly cash dividend on the company’s common stock to $0.41 for the first-quarter 2023 dividend, payable March 3, 2023, to holders of the Common Stock of record at the close of business on January 27, 2023. The first-quarter 2023 cash dividend will be the 337th consecutive quarterly dividend paid by Pfizer.